Karo Pharma AB

Buscomint Is Sanofi's Latest Offering Sanofi has extended its Buscopan gastrointestinal brand in the UK with the launch of Buscomint. Positioned as a “natural treatment for IBS and abdominal pain su

COVID And Domestic Woes Hit Boiron French homeopathy specialist Boiron blamed the impact of the global coronavirus pandemic, plus ongoing troubles in its domestic market, as it posted second-quarter s

Sweden’s Karo Pharma AB has expanded its consumer healthcare portfolio by acquiring the European rights to the Pevaryl antifungal brand from Johnson & Johnson ’s Cilag GmbH business for €58m ($62.7

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker . Roche Pays Vividion $135m Up Front In